We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-20.47%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$9.64B
AUM Growth
-$2.48B
Cap. Flow
+$636M
Cap. Flow %
6.6%
Top 10 Hldgs %
42.18%
Holding
1,253
New
58
Increased
575
Reduced
265
Closed
42

Top Buys

Rank Stock Value
1
PSA icon
Public Storage
PSA
+$250M
2
SPG icon
Simon Property Group
SPG
+$213M
3
VTR icon
Ventas
VTR
+$180M
4
KRMA
Global X Conscious Companies ETF
KRMA
+$147M
5
STOR
STORE Capital Corporation
STOR
+$132M

Top Sells

Rank Stock Value
1
O icon
Realty Income
O
+$178M
2
PEB icon
Pebblebrook Hotel Trust
PEB
+$99.3M
3
EQIX icon
Equinix
EQIX
+$96.7M
4
DEI icon
Douglas Emmett
DEI
+$88.8M
5
CONE
CyrusOne Inc Common Stock
CONE
+$84.5M

Sector Composition

Rank Sector Weight
1 Real Estate 70.9%
2 Technology 5.34%
3 Financials 3.16%
4 Healthcare 3.13%
5 Industrials 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ICPT
1026
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$12K ﹤0.01%
185
– –
ARNA
1027
DELISTED
Arena Pharmaceuticals Inc
ARNA
$12K ﹤0.01%
283
– –
MYOK
1028
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$12K ﹤0.01%
261
– –
ALEC icon
1029
Alector
ALEC
$169M
$11K ﹤0.01%
438
+49
+13% +$1.25K
APLS
1030
DELISTED
Apellis Pharmaceuticals
APLS
$11K ﹤0.01%
419
+58
+16% +$2.06K
AXSM icon
1031
Axsome Therapeutics
AXSM
$11.7B
$11K ﹤0.01%
195
– –
KRTX
1032
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$11K ﹤0.01%
147
– –
PRNB
1033
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$11K ﹤0.01%
185
– –
DNLI icon
1034
Denali Therapeutics
DNLI
$3.79B
$10K ﹤0.01%
587
+45
+8% +$939
KB icon
1035
KB Financial Group
KB
$39.5B
$10K ﹤0.01%
350
+50
+17% +$1.69K
XNCR icon
1036
Xencor
XNCR
$1.45B
$10K ﹤0.01%
320
– –
EIDX
1037
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$10K ﹤0.01%
212
– –
AHT
1038
Ashford Hospitality Trust
AHT
$20.8M
$9K ﹤0.01%
12
– –
ARVN icon
1039
Arvinas
ARVN
$530M
$9K ﹤0.01%
220
– –
AUPH icon
1040
Aurinia Pharmaceuticals
AUPH
$1.95B
$9K ﹤0.01%
596
+64
+12% +$1.13K
FATE icon
1041
Fate Therapeutics
FATE
$275M
$9K ﹤0.01%
410
– –
IRWD icon
1042
Ironwood Pharmaceuticals
IRWD
$586M
$9K ﹤0.01%
885
– –
TPTX
1043
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$9K ﹤0.01%
202
– –
EPZM
1044
DELISTED
Epizyme, Inc
EPZM
$9K ﹤0.01%
571
– –
TCF
1045
DELISTED
TCF Financial Corporation Common Stock
TCF
$9K ﹤0.01%
+400
New +$15K
AMRN
1046
Amarin Corp
AMRN
$297M
$8K ﹤0.01%
100
– –
CLPR
1047
Clipper Realty
CLPR
$46.4M
$8K ﹤0.01%
1,500
– –
LKFT
1048
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$8K ﹤0.01%
40
-6
-13% -$1.29K
INSM icon
1049
Insmed
INSM
$22.4B
$8K ﹤0.01%
504
– –
PCRX icon
1050
Pacira BioSciences
PCRX
$1.04B
$8K ﹤0.01%
236
– –
40 41
42
43 44

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q1 2020 Portfolio in Review

As of Q1 2020, Daiwa Securities Group held 1,253 positions worth $9.64B, down 20% from $12.1B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Daiwa Securities Group deployed $636M of net new capital in Q1 2020, opening 58 new positions and adding to 575 existing holdings. Its largest new stake was Global X Conscious Companies ETF: 6,650,000 shares worth $122M.

By sector, the portfolio is most concentrated in Real Estate at 71% of assets, down from 73% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Realty Income, an estimated $178M trimmed.

  • Daiwa Securities Group's largest Q1 2020 buy was Global X Conscious Companies ETF: 6,650,000 shares worth $122M.
  • Daiwa Securities Group added most to Public Storage in Q1 2020, an estimated $250M increase.
  • Daiwa Securities Group's biggest Q1 2020 reduction was Realty Income, cutting an estimated $178M.
  • Daiwa Securities Group fully exited RTX Corp in Q1 2020, selling an estimated $10.1M.
  • Daiwa Securities Group's ten largest holdings make up 42% of its $9.64B portfolio in Q1 2020.
  • Daiwa Securities Group opened 58 new positions and closed 42 in Q1 2020.
  • Daiwa Securities Group's portfolio value fell 20% quarter-over-quarter to $9.64B.

Based on Daiwa Securities Group's 13F filing for Q1 2020, filed 14 May 2020.